This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
IHS Markit's (INFO) OPIS Launches Carbon Credit Price Assessments
by Zacks Equity Research
IHS Markit's (INFO) OPIS assessments should help in transparent pricing of voluntary carbon credits.
Here's Why Investors Should Retain Accenture (ACN) Stock Now
by Zacks Equity Research
Raised guidance and strong balance sheet are driving Accenture (ACN) stock. Meanwhile, higher talent cost is a concern.
Here's Why You Should Hold Broadridge (BR) in Your Portfolio
by Zacks Equity Research
Broadridge's (BR) robust business model ensures significant recurring fee revenues. The company has a track record of consistent dividend payment.
NVEE vs. ACN: Which Stock Is the Better Value Option?
by Zacks Equity Research
NVEE vs. ACN: Which Stock Is the Better Value Option?
III vs. NVEE: Which Stock Is the Better Value Option?
by Zacks Equity Research
III vs. NVEE: Which Stock Is the Better Value Option?
3 Reasons Growth Investors Will Love NV5 (NVEE)
by Zacks Equity Research
NV5 (NVEE) possesses solid growth attributes, which could help it handily outperform the market.
NVEE vs. IT: Which Stock Is the Better Value Option?
by Zacks Equity Research
NVEE vs. IT: Which Stock Is the Better Value Option?
NV5 Holdings (NVEE) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
NV5 (NVEE) delivered earnings and revenue surprises of 56.94% and 9.65%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: NV5 Holdings (NVEE) Q3 Earnings Expected to Decline
by Zacks Equity Research
NV5 (NVEE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NVEE vs. ACN: Which Stock Is the Better Value Option?
by Zacks Equity Research
NVEE vs. ACN: Which Stock Is the Better Value Option?
CoreLogic Ups Guidance on Operational, Financial Growth
by Zacks Equity Research
CoreLogic (CLGX) keeps witnessing growth and profitability owing to successful execution of its strategic plan, housing-market fundamentals and strength across contracted wins and recurring revenues.
Here's Why You Should Hold ABM Industries in Your Portfolio
by Zacks Equity Research
The buyout of GCA Services Group aids ABM Industries' (ABM). Meanwhile, its debt-laden balance sheet is worrisome.
Should Value Investors Now Choose NV5 Global (NVEE) Stock?
by Zacks Equity Research
Let's see if NV5 Global (NVEE) stock is a good choice for value-oriented investors right now from multiple angles.
Here's Why You Should Hold Accenture (ACN) in Your Portfolio
by Zacks Equity Research
Acquisitions are one of the key growth strategies for Accenture (ACN).
NVEE or ACN: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
NVEE vs. ACN: Which Stock Is the Better Value Option?
3 Reasons Why Growth Investors Shouldn't Overlook NV5 (NVEE)
by Zacks Equity Research
NV5 (NVEE) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Reasons to Hold Broadridge Financial (BR) in Your Portfolio
by Zacks Equity Research
Broadridge's (BR) business model ensures significant recurring fee revenues from internal growth and acquisition-related synergies.
NVEE vs. ACN: Which Stock Is the Better Value Option?
by Zacks Equity Research
NVEE vs. ACN: Which Stock Is the Better Value Option?
Bright Near-Term Outlook for Consulting Services Industry
by Shuvra Shankar Dey
Digitization and adoption of technologies have become keys in helping the industry sail through these testing times.
Fiserv & LeaseQuery to Streamline Lease Accounting Processes
by Zacks Equity Research
The collaboration will provide Fiserv's (FISV) Prologue Financials accounting-software users access to LeaseQuery's CPA-approved lease-accounting software.
Accenture and Intel to Aid a Robotic Arm-Development Project
by Zacks Equity Research
The project will receive funding and technology from Accenture (ACN), Intel's neuromorphic technology and Applied Brain Research's algorithm.
Accenture Extends Tech Relationship With Anglo American
by Zacks Equity Research
The move should benefit Accenture's (ACN) Resources segment that caters to mining companies among others.
TransUnion Snaps Up Signal to Strengthen Marketing Solutions
by Zacks Equity Research
The buyout is part of TransUnion's (TRU) efforts to bolster its marketing abilities through people-based, identity-enabled marketing solutions.
MAXIMUS (MMS) Rides on Government Contracts, Debt Woe Stays
by Zacks Equity Research
With more than 40 years of experience, MAXIMUS (MMS) has grown to be a leading operator of government health and human-services programs globally.
Why Should You Retain Accenture (ACN) in Your Portfolio?
by Zacks Equity Research
Acquisitions enable Accenture (ACN) to enter new markets while diversifying and broadening its product portfolio.